The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: The next therapeutic frontier).
Alzheimer's and Dementia.
Times cited: 21
Evidence for a role of the rare p.A152T variant in mapt in increasing the risk for FTD-spectrum and Alzheimer's diseases.
Human Molecular Genetics.
Times cited: 85
The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration.
Times cited: 96